4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017696
CEO and Chairman sold 44,445 shares at an average $11.80 ($524,352)
- CEO and Chairman acquired 29,630 shares (option exercise)
- CEO and Chairman acquired 14,815 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…